In this short interview, Mr James Gilbert (Oxford University Hospitals NHS Foundation Trust, UK) sits down to discuss the clinical results of the WRAPSODY FIRST Study (NCT03644017), a first-in-human study intended to evaluate the efficacy and safety of the WRAPSODY Stent Graft in the treatment of venous outflow circuit obstructions in patients with renal disease.
Results show that the target lesion patency of the device was encouraging at 6 and 12 months.
- Unmet Needs in Current Stenosis Treatments
- Studied Device
- Study Design and Patient Population
- Key Findings
- Next Steps
- Take-home Messages
Recorded remotely from Oxford, 2022.
Videographer: Oliver Miles
Editor: Jordan Rance